#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.MedicalEntity|DCT|MedicalEntity
#T_RL=webanno.custom.TLINK|TLINK|BT_webanno.custom.MedicalEntity


#Text=Journalnotat 3 - 19.02.2023**
#Text=
#Text=Pasienten kommer tilbake etter å ha gjennomgått koronarangiografien.
1-1	0-12	Journalnotat	_	_	_	_	
1-2	13-14	3	_	_	_	_	
1-3	15-16	-	_	_	_	_	
1-4	17-27	19.02.2023	_	_	_	_	
1-5	27-28	*	_	_	_	_	
1-6	28-29	*	_	_	_	_	
1-7	31-40	Pasienten	_	_	_	_	
1-8	41-47	kommer	_	_	_	_	
1-9	48-55	tilbake	_	_	_	_	
1-10	56-61	etter	_	_	_	_	
1-11	62-63	å	_	_	_	_	
1-12	64-66	ha	_	_	_	_	
1-13	67-78	gjennomgått	_	_	_	_	
1-14	79-98	koronarangiografien	BEFORE	TREATMENT	_	_	
1-15	98-99	.	_	_	_	_	

#Text=Resultatene viser en betydelig stenose i venstre koronararterie, som krever en perkutan koronarintervensjon (PCI).
2-1	100-111	Resultatene	_	_	_	_	
2-2	112-117	viser	_	_	_	_	
2-3	118-120	en	_	_	_	_	
2-4	121-130	betydelig	_	_	_	_	
2-5	131-138	stenose	OVERLAP[1]	CONDITION[1]	_	_	
2-6	139-140	i	OVERLAP[1]	CONDITION[1]	_	_	
2-7	141-148	venstre	OVERLAP[1]	CONDITION[1]	_	_	
2-8	149-163	koronararterie	OVERLAP[1]	CONDITION[1]	_	_	
2-9	163-164	,	_	_	_	_	
2-10	165-168	som	_	_	_	_	
2-11	169-175	krever	_	_	_	_	
2-12	176-178	en	_	_	_	_	
2-13	179-187	perkutan	OVERLAP[2]	TREATMENT[2]	_	_	
2-14	188-207	koronarintervensjon	OVERLAP[2]	TREATMENT[2]	_	_	
2-15	208-209	(	OVERLAP[2]	TREATMENT[2]	_	_	
2-16	209-212	PCI	OVERLAP[2]	TREATMENT[2]	_	_	
2-17	212-213	)	OVERLAP[2]	TREATMENT[2]	_	_	
2-18	213-214	.	_	_	_	_	

#Text=Jeg starter pasienten på en behandling med en P2Y12-inhibitor og en statin for å reducere risikoen for nye kardiovaskulære hendelser.
3-1	215-218	Jeg	_	_	_	_	
3-2	219-226	starter	_	_	_	_	
3-3	227-236	pasienten	_	_	_	_	
3-4	237-239	på	_	_	_	_	
3-5	240-242	en	_	_	_	_	
3-6	243-253	behandling	AFTER	TREATMENT	OVERLAP|OVERLAP	3-9[3_0]|3-14	
3-7	254-257	med	_	_	_	_	
3-8	258-260	en	_	_	_	_	
3-9	261-266	P2Y12	AFTER[3]	TREATMENT[3]	OVERLAP	3-6[0_3]	
3-10	266-267	-	AFTER[3]	TREATMENT[3]	_	_	
3-11	267-276	inhibitor	AFTER[3]	TREATMENT[3]	_	_	
3-12	277-279	og	_	_	_	_	
3-13	280-282	en	_	_	_	_	
3-14	283-289	statin	AFTER	TREATMENT	OVERLAP	3-6	
3-15	290-293	for	_	_	_	_	
3-16	294-295	å	_	_	_	_	
3-17	296-304	reducere	_	_	_	_	
3-18	305-313	risikoen	_	_	_	_	
3-19	314-317	for	_	_	_	_	
3-20	318-321	nye	_	_	_	_	
3-21	322-337	kardiovaskulære	_	_	_	_	
3-22	338-347	hendelser	_	_	_	_	
3-23	347-348	.	_	_	_	_	
